Skip to content

13F-HR/A filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2019-12-31, filed 2020-04-09, with 52 holding rows worth $525,115,000.

Accession
0001387131-20-003809
Filed
2020-04-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, amendment of type restatement, 52 entries on the cover page, a total value of $525,115,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $525,115,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS200,000$64,372,000thousands by filing dateput
SPDR SER TR78464A870S&P BIOTECH500,000$47,556,000thousands by filing dateput
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR200,000$27,824,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock575,500$27,112,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock200,000$20,672,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM150,000$19,329,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM650,000$17,992,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM700,000$15,932,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A75,000$15,332,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM575,000$13,898,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock1,175,000$13,536,000thousands by filing date
IMMUNOVANT INC45258J102COM800,000$12,696,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,250,000$12,175,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock600,000$12,156,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM150,000$12,017,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM150,000$10,829,000thousands by filing datecall
IMMUNOMEDICS INC452907108COM500,000$10,580,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock3,000,000$10,350,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM350,000$9,688,000thousands by filing datecall
ARVINAS INC04335A105COM225,000$9,245,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM300,000$9,186,000thousands by filing dateput
SAREPTA THERAPEUTICS INC803607100COM65,000$8,388,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR750,000$8,025,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM400,000$7,892,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM430,000$7,742,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM250,000$7,655,000thousands by filing datecall
KALVISTA PHARMACEUTICALS INC483497103COM415,000$7,391,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO450,000$6,984,000thousands by filing date
IVERIC BIO INC46583P102COM750,000$6,435,000thousands by filing date
ARQULE INC04269E107COM300,000$5,988,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM275,000$5,382,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW250,000$5,360,000thousands by filing datecall
APELLIS PHARMACEUTICALS INC03753U106COM175,000$5,359,000thousands by filing date
Viewra, Inc92672L107COM1,200,000$5,064,000thousands by filing date
INVESCO CURRENCYSHARES SWISS46138R108SWISS FRANC52,000$4,949,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock200,000$4,776,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock800,000$4,584,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A350,000$3,871,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM235,000$3,762,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR224,359$3,085,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM450,000$2,750,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM1,150,000$2,737,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM33,400$2,655,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM40,000$2,178,000thousands by filing date
CHIASMA INC16706W102COM425,000$2,108,000thousands by filing date
KADMON HLDGS INC48283N106COM462,500$2,095,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM275,000$1,939,000thousands by filing date
INVESCO CURRENCYSHARES BRITISH46138m109INDX FD11,600$1,490,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM50,500$968,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock63,000$699,000thousands by filing date
ANAPTYSBIO INC032724106COM11,500$187,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM38,340$140,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-20-001616 superseded2020-02-14acceptance time not in the bulk data set
13F-HR/A 0001387131-20-003809this filing2020-04-09acceptance time not in the bulk data set